Marketing-authorisation holder
Teligent
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CEFOTAN10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1GM BASE/VIAL | 2GM BASE/VIAL · Injectable | Cefotetan | United States | Marketed | 1985 |
| FLURANDRENOLIDE0.05% · Ointment | Fludroxycortide | United States | Marketed | 2016 |
| M.V.I.-12 LYOPHILIZED100mg/vial; 0.06mg/vial; 0.005mg/vial; 15mg/vial; 5mcg/vial; 0.4mg/vial; 40mg/vial; 4mg/vial; 5'-phosphate sodium 3.6mg/vial; 3mg/vial; 1mg/vial; 10mg/vial · Injectable | Ascorbic acid, Biotin, Vitamin b12, Dexpanthenol, Ergocalciferol, Folic acid, Niacinamide, Vitamin b6, Vitamin b2, Vitamin b1, Vitamin a, Vitamin e | United States | Not marketed |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past |
|---|
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder
Work with Prognia
Keep Teligent’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call